The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

That was before the spectacular success of Hemlibra, a bispecific antibody-based drug that mimics the function of Factor VIII by bridging clotting factors on either side of it in the clotting pathway.

Sobi’s Sanofi-partnered efanesoctocog alfa has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA ...

The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.

Thus, although the reduced production of most clotting factors in patients ... coupled with increased von Willebrand factor and factor VIII levels, increases the risk of coagulopathy.

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

Sam Smith explores how more than a thousand haemophiliacs in the UK acquired HIV through their treatment - in what's come to be known as the contaminated blood scandal.

Teachers, first responders, medical workers, active military, and veterans can get 55% off your their first box, free shipping, and 15% off all other boxes over the next year.

When Henry VII died in 1509, this popular eighteen-year-old prince, known for his love of hunting and dancing, became King Henry VIII. Soon after he obtained the papal dispensation required to ...